Annotation Detail

Information
Associated Genes
FOLH1
Associated Variants
FOLH1 MUTATION
FOLH1 MUTATION
Associated Disease
prostate carcinoma
Source Database
DisGeNET
Description
In a recent report, we established a nanomicelle-based strategy to deliver p110β-specific inhibitor TGX221 to prostate cancer cells by conjugating the surface of nanomicelles with a RNA aptamer against prostate specific membrane antigen (PSMA) present in all clinical prostate cancers.
Pubmed
25620467
Section of the abstract supporting the evidence
BACKGROUND
Number of the section of the abstract supporting the evidence
1
Number of the sentence supporting the evidence
4
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.0325730246496364
Drugs